Conatus Pharmaceuticals Inc. (CNAT)

[biotech2010]

Stifel Nicolaus, a major research house, upped their price target to $9 and continued its Buy recommendation.

Stifel’s Equity Research Group is a recognized leader with a deep and broad spectrum of coverage. Our award-winning analysts are thought leaders, many with hands-on experience in their respective industries, offering objective, in-depth analysis and timely, actionable research ideas.

Research

1,718 global stocks under coverage

122 analysts across 12 sectors


Rankings
Largest U.S. equity research platform
Second largest provider of global small cap coverage
Fourth largest provider of global financial coverage
Top 10 provider of U.S. equity coverage in:
Consumer & Retail
Diversified Industrials
Healthcare
Internet & Media
Real Estate
Technology
Transportation